SG81391G - Use of dipeptide derivatives for the preparation of medicaments for the treatment of sufferers from amyotrophic lateral sclerosis - Google Patents
Use of dipeptide derivatives for the preparation of medicaments for the treatment of sufferers from amyotrophic lateral sclerosisInfo
- Publication number
- SG81391G SG81391G SG813/91A SG81391A SG81391G SG 81391 G SG81391 G SG 81391G SG 813/91 A SG813/91 A SG 813/91A SG 81391 A SG81391 A SG 81391A SG 81391 G SG81391 G SG 81391G
- Authority
- SG
- Singapore
- Prior art keywords
- sufferers
- medicaments
- preparation
- treatment
- lateral sclerosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE3446127 | 1984-12-18 | ||
DE19843447260 DE3447260A1 (de) | 1984-12-22 | 1984-12-22 | Verwendung von dipeptidderivaten zur behandlung von an amyotropher lateralsklerose erkrankten |
Publications (1)
Publication Number | Publication Date |
---|---|
SG81391G true SG81391G (en) | 1991-11-15 |
Family
ID=25827483
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG813/91A SG81391G (en) | 1984-12-18 | 1991-10-05 | Use of dipeptide derivatives for the preparation of medicaments for the treatment of sufferers from amyotrophic lateral sclerosis |
Country Status (8)
Country | Link |
---|---|
US (1) | US4788179A (da) |
EP (1) | EP0185210B1 (da) |
JP (1) | JPH0637395B2 (da) |
DE (1) | DE3583220D1 (da) |
DK (1) | DK585985A (da) |
IE (1) | IE58849B1 (da) |
IL (1) | IL77083A (da) |
SG (1) | SG81391G (da) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63316724A (ja) * | 1987-06-19 | 1988-12-26 | Nippon Shinyaku Co Ltd | 抗けいれん剤 |
US5151497A (en) * | 1989-02-21 | 1992-09-29 | Japan Tobacco Inc. | Histidyl peptide derivatives |
EP2327404A1 (en) * | 1994-11-08 | 2011-06-01 | Avicena Group, Inc. | Use of creatine or creatine analogs for the treatment of diseases of the nervous system |
ATE228760T1 (de) * | 1995-10-24 | 2002-12-15 | Merck & Co Inc | Thrombininhibitoren |
US20020151502A1 (en) * | 1997-10-09 | 2002-10-17 | Albert Sattin | Tri-peptides for neurological and neurobehavior applications |
US20050233973A1 (en) * | 1997-10-09 | 2005-10-20 | Albert Sattin | Tri-peptides for antidepressant applications |
US6475989B1 (en) | 1997-10-09 | 2002-11-05 | Albert Sattin | Use of pyroglutamyl-glutamyl-prolyl amide (EEP) for neurological and neurobehavioral disorders |
EP1065931A4 (en) * | 1998-04-02 | 2006-10-11 | Avicena Group Inc | COMPOSITIONS CONTAINING CREATINE COMBINED WITH A SECOND AGENT |
US20060128671A1 (en) * | 1998-04-02 | 2006-06-15 | The General Hospital Corporation | Compositions containing a combination of a creatine compound and a second agent |
JP2004516286A (ja) | 2000-12-18 | 2004-06-03 | メルク エンド カムパニー インコーポレーテッド | ベンジルアミン誘導体およびそれのトロンビン阻害薬としての使用 |
US6528503B2 (en) | 2000-12-18 | 2003-03-04 | Merck & Co., Inc. | Thrombin inhibitors |
US8015737B2 (en) * | 2001-02-08 | 2011-09-13 | Venegas Jr Frank | Barrier cover |
CA2436176A1 (en) | 2001-02-09 | 2002-08-22 | Merck & Co., Inc. | Thrombin inhibitors |
US7084134B2 (en) | 2002-05-02 | 2006-08-01 | Merk & Co., Inc. | Thrombin inhibitors |
AU2003238872A1 (en) * | 2002-06-04 | 2003-12-19 | Avicena Group, Inc. | Methods of treating cognitive dysfunction by modulating brain energy metabolism |
US7462595B2 (en) * | 2004-09-17 | 2008-12-09 | Prange Jr Arthur Jergen | Methods for treating cancer-related fatigue |
WO2007133673A2 (en) * | 2006-05-11 | 2007-11-22 | Avicena Group, Inc. | Methods of treating a neurological disorder with creatine monohydrate |
US9233099B2 (en) | 2012-01-11 | 2016-01-12 | University Of Cincinnati | Methods of treating cognitive dysfunction by modulating brain energy metabolism |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE408300B (sv) * | 1974-10-16 | 1979-06-05 | Gruenenthal Chemie | Sett att framstella nya dipeptidderivat |
DE2615455C2 (de) * | 1976-04-09 | 1985-06-20 | Grünenthal GmbH, 5190 Stolberg | N-Acyl-L-histidyl-L-prolin (N-substituierte)-amide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen |
HU180926B (en) * | 1979-06-28 | 1983-05-30 | Richter Gedeon Vegyeszet | Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem |
US4608365A (en) * | 1984-03-30 | 1986-08-26 | University Of Southern California | Treatment of neurologic functions |
-
1985
- 1985-11-01 IE IE269785A patent/IE58849B1/en not_active IP Right Cessation
- 1985-11-18 IL IL77083A patent/IL77083A/xx not_active IP Right Cessation
- 1985-11-19 DE DE8585114680T patent/DE3583220D1/de not_active Expired - Fee Related
- 1985-11-19 EP EP85114680A patent/EP0185210B1/de not_active Expired - Lifetime
- 1985-12-11 US US06/807,845 patent/US4788179A/en not_active Expired - Lifetime
- 1985-12-17 JP JP60282139A patent/JPH0637395B2/ja not_active Expired - Lifetime
- 1985-12-17 DK DK585985A patent/DK585985A/da not_active Application Discontinuation
-
1991
- 1991-10-05 SG SG813/91A patent/SG81391G/en unknown
Also Published As
Publication number | Publication date |
---|---|
IE58849B1 (en) | 1993-11-17 |
DK585985D0 (da) | 1985-12-17 |
EP0185210A3 (en) | 1988-09-14 |
IL77083A (en) | 1991-06-10 |
EP0185210A2 (de) | 1986-06-25 |
JPS61145121A (ja) | 1986-07-02 |
IL77083A0 (en) | 1986-04-29 |
JPH0637395B2 (ja) | 1994-05-18 |
DE3583220D1 (de) | 1991-07-18 |
IE852697L (en) | 1986-06-18 |
EP0185210B1 (de) | 1991-06-12 |
DK585985A (da) | 1986-06-19 |
US4788179A (en) | 1988-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL76591A (en) | Pharmaceutical compositions containing ifn-ypsilon for the treatment or prevention of malignant or viral diseases | |
EP0243002A3 (en) | Pharmaceutical composition for the treatment of periodontal diseases | |
HU895334D0 (en) | Process for the preparation of nasal pharmaceutical compositions | |
SG81391G (en) | Use of dipeptide derivatives for the preparation of medicaments for the treatment of sufferers from amyotrophic lateral sclerosis | |
ZA82124B (en) | Bandage for administering beneficial drug | |
AP8900133A0 (en) | Pharmaceutical composition for the prevention of sexually transmitted diseases | |
PT81015B (en) | Process for the preparation of piridazo-diazocine derivatives and pharmaceutical compositions therewith | |
IL86247A (en) | Preparation of a protein composition for treatment of amyotrophic lateral sclerosis | |
ZA829408B (en) | Use of peptides as medicament | |
IL76561A (en) | Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases | |
DE3261760D1 (en) | Pharmaceutical compositions for the treatment of skin | |
ZA864074B (en) | Process for the preparation of gamma-globulins for intravenous administration | |
ZA82361B (en) | Pharmaceutical composition for treating diseases of the oral cavity | |
PT79858B (en) | Process for the preparation of azolyl-aryl-alcanol and pharmaceutical compositions therewith | |
GB2162748B (en) | Medicinal composition for the treatment or prevention of acne by oral administration | |
GB2105992B (en) | Pharmaceutical composition for treatment of cardio-vascular diseases | |
DE3272384D1 (en) | Medicinal composition for the treatment of certain neuroviroses | |
GB2170403B (en) | Medicament for treatment of asthma and preparation thereof | |
ZA855761B (en) | Use of alkylenediamine derivatives for the treatment of blood flow disturbances and pharmaceutical compositions containing them | |
PT79990A (en) | Process for the preparation of diazepine-indoles and of pharmaceutical compositions therewith | |
IL89057A0 (en) | Pharmaceutical compositions for the treatment of ulcers containing quinoline or benzodiazine derivatives | |
IL84012A0 (en) | Pharmaceutical composition for the treatment of high blood pressure | |
RO92740B1 (ro) | Compozitie medicamentoasa pentru tratamentul otitelor | |
IL62286A0 (en) | Preparation comprising glycyrhizin for the treatment of oral diseases | |
IL82376A (en) | Pharmaceutical composition for the treatment of inflammatory conditions |